Gefapixant will reduce cough frequency, thereby improving patients’ quality of life.
Regulatory
Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.
Posted inNew Drugs, Regulatory
Susvimo: Pioneering Implant for Treating Wet Age-Related Macular Degeneration
Roche offered a convenient replacement for the traditional Lucentis.
Posted inInfections, New Drugs, Regulatory
Brexafemme: New Drug for Vaginal Yeast Infection
Scynexis offered ibrexafungerp, a new antifungal medication for vulvovaginal candidiasis treatment.
Posted inNeuroscience, New Drugs, Regulatory
Quviviq: New Sleeping Pill
Daridorexant will help treat insomnia.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Molnupiravir Approved in the U.S.
An oral antiviral drug by Merck & Co. has joined the armamentarium of the pharmacological fight against COVID-19.
Posted inCOVID-19, Infections, New Drugs, Regulatory
MIR 19: Surprising New Drug to Treat Coronavirus
A Russian drug for COVID-19 has adopted a powerful RNA interference technology.
Posted inCardiology, Metabolism, New Drugs, Rare/Orphan Diseases, Regulatory
Leqvio: Newest Drug Against ‘Very Bad’ Cholesterol
Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.